Congratulations to the winners and finalists of the 2011 ViE Awards

Award

Best Therapeutic Vaccine (approved or in development)






Best Prophylactic Vaccine (approved or in development)







Best Pharmaceutical Vaccine Pipeline





Best Pharma Executive









Best Vaccine Partnership / Alliance / License






Best Early-Stage Vaccine Biotech








Biotech CEO of the Year












Best Contract Research Organisation








Best Clinical Trial Site / Network







Best Contract Manufacturer Organisation

Winner

NicVax & Nabi Biopharmaceuticals







Dengue Fever and sanofi pasteur








Novartis Vaccines and Diagnostics





Dr Emilio Emini, Chief Scientific Officer, Vaccine Research, Pfizer








Joint Winners GlaxoSmithKline & GAVI Alliance and Pfizer & GAVI Alliance






Medicago








Mr Fuad El-Hibri, Chief Executive Officer and Chairman, Emergent BioSolutions











Accelovance








VaxNet







Baxter BioPharma Solutions

Finalists

• Prostvac and Bavarian Nordic
• OncoVEX and BioVex
• VGX-3100 and Inovio Pharmaceuticals
• NicVax and Nabi Biopharmaceuticals
• Tovaxin and Opexa Therapeutics
• TransVax and Vical

• Preflucel and Baxter International
• Heplisav and Dynavax Technologies
• Herpes Zoster and GSK Biologicals
• H5N1 and Medicago
• Bexsero and Novartis Vaccines and Diagnostics
• Dengue Fever and sanofi pasteur

• GSK Biologicals
• Novartis Vaccines and Diagnostics
• sanofi pasteur

• Dr Altaf Lal, Chief Executive Officer, MSD Wellcome Trust Hilleman Laboratories
• Dr Emilio Emini, Chief Scientific Officer, Vaccine Research, Pfizer
• Dr Thomas Breuer, Senior Vice President Global Clinical R&D, Chief Medical Officer, GSK Biologicals

• MSD Wellcome Trust Hilleman Laboratories
• GlaxoSmithKline and GAVI Alliance
• Pfizer and GAVI Alliance
• sanofi pasteur and International Vaccine Institute (IVI)

• Argos Therapeutics
• BioVest International
• Inviragen
• Ligocyte Pharmaceuticals
• Liquidia Technologies
• Medicago

• Mr Anders Hedegaard, President and CEO, Bavarian Nordic
• Dr Dino Dina, President and CEO, Dynavax Technologies
• Dr Robert House, President, DynPort Vaccine Company LLC (DVC), a CSC Company
• Mr Fuad El-Hibri, CEO and Chairman, Emergent BioSolutions
• Dr J Joseph Kim, President and CEO, Inovio Pharmaceuticals

• Accelovance
• Covance
• Encorium
• ICON Clinical Research
• Parexel
• Quintiles

• Clinical Research Advantage
• Elite Research
• J. Lewis Research
• PMG Research
• VaxNet
• Wake Research

• Baxter BioPharma Solutions
• KBI BioPharma
• Lonza
• Fujifilm Diosynth Biotechnologies
• SAFC
• VGXi